Patents Assigned to Artcline GmbH
  • Publication number: 20200002673
    Abstract: A method for preparing a leukocyte preparation from a leukocyte fraction and a correspondingly prepared or obtainable leukocyte preparation and its use. The methods include: a) sedimenting the leukocyte fraction removing leukocyte supernatant from the sediment, wherein the leukocyte supernatant is collected or remains in a leukocyte container, b) sedimenting the leukocytes in the leukocyte container, c) washing the sediment in the leukocyte container with a saline solution, and d) resuspending the sediment in the leukocyte container in a storage solution.
    Type: Application
    Filed: July 9, 2019
    Publication date: January 2, 2020
    Applicants: ARTCLINE GMBH, FRAUNHOFER-GESELLSCHAFT ZUR FÖRDERUNG DER ANGEWANDTEN FORSCHUNG E.V.
    Inventors: Jens Altrichter, Steffen Mitzner, Antje Schwarz, Kathleen Selleng, Fanny Doss, Stephanie Koch
  • Patent number: 10377987
    Abstract: A method for preparing a leukocyte preparation from a leukocyte fraction and a correspondingly prepared or obtainable leukocyte preparation and its use. The method includes: a) sedimenting the leukocyte fraction removing leukocyte supernatant from the sediment, wherein the leukocyte supernatant is collected or remains in a leukocyte container, b) sedimenting the leukocytes in the leukocyte container, c) washing the sediment in the leukocyte container with a saline solution, and d) resuspending the sediment in the leukocyte container in a storage solution.
    Type: Grant
    Filed: December 8, 2014
    Date of Patent: August 13, 2019
    Assignees: Artcline GmbH, Fraunhofer-Gesellschaft Zur Forderung Der Angewandten Forschung E.V.
    Inventors: Jens Altrichter, Steffen Mitzner, Antje Lübcke, Kathleen Selleng, Fanny Doss, Stephanie Koch
  • Patent number: 9265875
    Abstract: The present invention relates to a method for treating blood composition disorders and blood function disorders. Said method comprises steps, in which blood or blood plasma of a patient is brought into extracorporeal contact with a second fluid (bioequivalent), wherein said second fluid is blood or modified blood, which comprises at least granulocytes, thrombocytes, and erythrocytes. Furthermore, the invention relates to devices for performing said method and to the use of such a device or blood or modified blood, which comprises granulocytes, thrombocytes, and erythrocytes, for treating blood composition disorders and blood function disorders.
    Type: Grant
    Filed: February 20, 2009
    Date of Patent: February 23, 2016
    Assignee: Artcline GmbH
    Inventor: Steffen Mitzner